Safety question
Is Vinpocetine safe?
Generally yes, with attention to dose and timing. Vinpocetine scores 4/5. Adverse reactions are uncommon, minor, and reversible on stopping. The main risks are dose-related — starting at the low end of the clinical range and titrating up gives the best safety margin.
Safety score
4 / 5
Evidence grade
B
Severe reactions on file
0
Pubmed cites
600
Key facts
- typical dose
- 5–30 mg
- dose frequency
- 2-3 doses
- timing
- with meals
- with food
- with food
- half-life
- 2 hours
- safety score
- 4/5
- evidence grade
- B
- class
- neuroprotective
- PubMed citations
- 600
- legal status (US)
- Banned
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Prescription-only
- legal status (AU)
- Prescription-only
- restrictions
- US (FDA dietary supplement ban 2019)
- primary mechanism
- Inhibits phosphodiesterase 1 (PDE1), increasing intracellular cGMP and producing vasodilation specifically in cerebral arterioles.
Common side effects
- Mild blood pressure decreasemild
Uncommon side effects
- GI upsetmild
Banned or restricted in
- US (FDA dietary supplement ban 2019)
Restrictions can include outright bans, prescription-only classification, anti-doping prohibitions (WADA), or supplement-marketing restrictions. Check your local regulator before purchasing.
Who should not take Vinpocetine
- Pregnant or breastfeeding individuals — most nootropics have not been adequately studied in pregnancy, and the precautionary principle applies.
- Anyone on a prescription medication that overlaps mechanistically (stimulants, SSRIs, MAOIs, beta-blockers, anticoagulants) — clear interactions with your prescribing clinician before adding Vinpocetine.
- Anyone with significant cardiovascular, hepatic, renal, or psychiatric disease — established conditions raise the baseline risk for any new compound.
- Minors — almost no nootropics have a paediatric safety record, and developing brains are differently sensitive.
What "safe" means here
Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.
A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.
Full mechanism, citations, and dose guidance for Vinpocetine are on the main reference page — see Vinpocetine. For the dose-by-dose breakdown, see Vinpocetine dosage. To check stack interactions, use the interaction checker.
This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.